Fogh, S., Hirsch, A.E., Goldberg, S.I., Rosenberg, C.L., Taghian, A.G., Powell, S.N., Kachnic, L.A. and Langmead, J.P. (2011) Use of Tamoxifen with Postsurgical Irradiation May Improve Survival in Estrogen and Progesterone Receptor-Positive Male Breast Cancer. Clinical Breast Cancer, 11, 39-45.
http://dx.doi.org/10.3816/CBC.2011.n.007

has been cited by the following article:

• TITLE: Male Breast Cancer Clinical Features, Risk Factors, and Current Diagnostic and Therapeutic Approaches

  AUTHORS: Mojgan Haji Seyed Ebrahim Darkeh, Edward Azavedo

  KEYWORDS: Breast Cancer, Male Breast Cancer, Treatment, Diagnosis, Prognosis

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.5 No.17, September 12, 2014

  ABSTRACT: Objective: To review presentation, diagnosis, treatment and prognosis of male breast cancer. Method: A systematic review of the English language literature between 1990 and 2013 was conducted to identify studies relevant to the objective. Searches were carried out on the database PubMed, by using the title term “male breast cancer”. Results: The majority of male patients present with a painless, firm, subareolar lump. Experience of male breast imaging is good but limited. However, there is no definitive therapeutic algorithm. Men are often treated with mastectomy instead of breast conserving surgery and mostly tamoxifen is used as an adjuvant therapy. The most important prognostic factors are tumor size and lymph node status in the armpit. Conclusion: More increased awareness and further research are needed to improve the diagnosis and treatment of this disease.